CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
138 hedge funds and large institutions have $1.31B invested in Clovis Oncology, Inc. in 2014 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 58 increasing their positions, 38 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
8% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 25
1% less funds holding
Funds holding: 140 → 138 (-2)
Holders
138
Holding in Top 10
7
Calls
$31M
Puts
$24.6M
Top Buyers
| 1 | +$37.4M | |
| 2 | +$36.6M | |
| 3 | +$26.3M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$16.7M |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$13.4M |
Top Sellers
| 1 | -$50.5M | |
| 2 | -$32.8M | |
| 3 | -$19.3M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$13M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$11.2M |